跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZEVTERA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZEVTERA
Authorized
STANDARD
ZEVTERA
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
adc45c17aabdb45e
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
adc45c17aabdb45e
Drug Approval Canada Name
ZEVTERA
Product Name
ZEVTERA
Status
Marketed
Status Date
2018-03-20
Original Market Date
2018-03-20
Din
02446685
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.06.20
Atc Original
J01DI01 CEFTOBIPROLE MEDOCARIL
Atc Name
j 01 di 01
Aig Number
0152470001
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
CEFTOBIPROLE (CEFTOBIPROLE MEDOCARIL SODIUM)
500 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
adc45c17aabdb45e
Type
Standard
Back to Health Canada Approvals